Steen Marten 4
4 · Strongbridge Biopharma plc · Filed May 17, 2018
Insider Transaction Report
Form 4
Steen Marten
Director
Transactions
- Award
Stock Options (Right to Buy)
2018-05-15+40,000→ 40,000 total(indirect: By HealthCap VI, L.P.)Exercise: $7.75From: 2019-05-15Exp: 2028-05-15→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]Based on his affiliation with HealthCap VI, L.P., the Reporting Person may be deemed the beneficial owner of these securities. The Reporting Person expressly disclaims beneficial ownership over these securities except to the extent of his pecuniary interest therein.